Nov 5 - Regeneron Pharmaceuticals Inc reported a 12.6% rise in third-quarter profit on Tuesday, boosted by higher sales of its eczema drug, Dupixent.
Net income rose to $669.6 million, or $5.86 per share, in the quarter ended Sept. 30, from $594.7 million, or $5.17 per share, a year earlier.
Total revenue rose 23.1% to $2.05 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
These proven wealth builders could be exactly what you're searching for right now.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.
Since 2021, Dogecoin (DOGE) has consistently been one of the largest cryptocurrencies in the market. The token has attracted tens of billions in investment and is up more than 27,000% since its launch. While the price has fallen considerably since highs, the token has held its own and performed well in 2024. Some do not see the growth stopping anytime soon. According to some analysts, DOGE could reach — and even surpass — the $100 mark. Don't Miss: Dogecoin millionaires are increasing — investor
“We’re definitely not doing what you would think somebody with our income could do with the money,” one six-figure earner said.
It's possible to construct a winning long-term investment strategy with just low-cost index funds.